Strong Results By BIOCON , Stock AGAIN ON RADAR

Biocon Q2: Cons Net Profit At Rs 102.1 Cr Vs Poll Of Rs 92.5 Cr

Biocon Q2: Cons Revenue At Rs 740.8 Cr Vs Poll Of Rs 718 Cr

Biocon Q2: Cons EBITDA At Rs 176 Cr Vs Poll Of Rs 152.6 Cr

Biocon Q2: Cons Operating Margin At 23.7% Vs Poll Of 21.3%

I HAD CLEARLY TOLD TO GO LONG ON THE STOCK AT 305 WHEN IT BROKE OUT 

http://trendzofmarket.blogspot.in/2013/07/biocon-heading-to-325-330.html 

AND STOCK HIT 330

AGAIN GAVE CALL TO BUY ABV 330 WHEN IT BROKE OUT AND STOCK HIT 360 LEVELS

http://trendzofmarket.blogspot.in/2013/07/biocon-fresh-break-out-above-330.html

NOW AGIAN IAM FEELING BULLISH ON THE STOCK ABV 342 ON CLOSING BASIS SL 335 ON CLOSING BASIS FOR 360-365 LEVELS IN SHORT TO MEDIUM TERM